In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Third Harmonic Bio Inc’s stock clocked out at $10.32, down -4.44% from its previous closing price of $10.80. In other words, the price has decreased by -$4.44 from its previous closing price. On the day, 93277.0 shares were traded. THRD stock price reached its highest trading level at $10.85 during the session, while it also had its lowest trading level at $9.99.
Ratios:
To gain a deeper understanding of THRD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 42.50 and its Current Ratio is at 42.50. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on August 09, 2024, Upgraded its rating to Overweight and sets its target price to $20 from $12 previously.
On June 18, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $23.
On June 07, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $18.Raymond James initiated its Outperform rating on June 07, 2024, with a $18 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 08 ’24 when Conner Edward R. sold 2,117 shares for $15.00 per share. The transaction valued at 31,755 led to the insider holds 0 shares of the business.
BVF PARTNERS L P/IL sold 1,000,000 shares of THRD for $14,300,000 on Oct 29 ’24. The See Explanation of Responses now owns 176,692 shares after completing the transaction at $14.30 per share. On Oct 28 ’24, another insider, Conner Edward R., who serves as the Chief Medical Officer of the company, sold 2,673 shares for $15.00 each. As a result, the insider received 40,095 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THRD now has a Market Capitalization of 465002688 and an Enterprise Value of 195743200.
Stock Price History:
Over the past 52 weeks, THRD has reached a high of $16.94, while it has fallen to a 52-week low of $8.07. The 50-Day Moving Average of the stock is -18.17%, while the 200-Day Moving Average is calculated to be -15.67%.
Shares Statistics:
It appears that THRD traded 194.31K shares on average per day over the past three months and 188140 shares per day over the past ten days. A total of 44.73M shares are outstanding, with a floating share count of 17.43M. Insiders hold about 61.32% of the company’s shares, while institutions hold 39.99% stake in the company. Shares short for THRD as of 1732838400 were 3056584 with a Short Ratio of 15.73, compared to 1730332800 on 2876298. Therefore, it implies a Short% of Shares Outstanding of 3056584 and a Short% of Float of 13.56.
